Association between tumor mutational burden (TMB) assessed by whole-exome sequencing (WES) and outcomes of pembrolizumab (pembro) monotherapy

被引：6

作者：

Cristescu, Razvan ^{[1
]}

Aurora-Garg, Deepti ^{[1
]}

Albright, Andrew ^{[1
]}

Xu, Lei ^{[1
]}

Liu, Xiao Qiao ^{[2
]}

Loboda, Andrey ^{[1
]}

Lang, Lixin ^{[1
]}

Jin, Fan ^{[1
]}

Snyder, Alexandra ^{[1
]}

Lunceford, Jared ^{[1
]}

机构：

[1] Merck & Co Inc, Kenilworth, NJ USA

[2] MSD China, Beijing, Peoples R China

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-LB-261

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-261

引用

页数：2

共 50 条

[1] Prognosis Determined by Tumor Mutational Burden (TMB) Using Whole Exome Sequencing (WES)
Fernandez, E.
Eng, K.
Sboner, A.
Elemento, O.
Song, W.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1013 - 1013
[2] Influence of low tumor content on tumor mutational burden estimation by whole-exome sequencing and targeted panel sequencing
Zhang, Wenxin
Wang, Ruixia
Fang, Huan
Ma, Xiangyuan
Li, Dan
Liu, Tao
Chen, Zhenxi
Wang, Ke
Hao, Shiguang
Yu, Zicheng
Chang, Zhili
Na, Chenglong
Wang, Yin
Bai, Jian
Zhang, Yanyan
Chen, Fang
Li, Miao
Chen, Chao
Wei, Liangshen
Li, Jinghua
Chang, Xiaoyan
Qu, Shoufang
Yang, Ling
Huang, Jie
CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (05):
[3] Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing
Zhou, Chuang
Chen, Song
Xu, Fei
Wei, Jinwang
Zhou, Xiaoyu
Wu, Zhiqiang
Zhao, Longshuan
Liu, Jun
Guo, Wenbo
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
[4] Tumor mutational burden estimated by whole-exome sequencing across multiple cancer types.
Xu, Fei
Wei, Jinwang
Zhang, Xiaochen
Dai, Chun
Wang, Guan
Xu, Qiang
CANCER RESEARCH, 2021, 81 (13)
[5] Comparison of Tumor Mutational Burden (TMB) Derived from Whole Exome and Large Panel Sequencing in Lung Cancer
Shan, G.
Zhao, L.
Li, L.
Liu, B.
Cheng, G.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2385 - S2385
[6] Harmonizing tumor mutational burden analysis Insights from a multicenter study using in silico reference data sets in clinical whole-exome sequencing (WES)
Yu, Lijia
Zhang, Yuanfeng
Wang, Duo
Li, Lin
Zhang, Rui
Li, Jinming
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 (04) : 408 - 419
[7] Data Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories
Qiu, Ping
Pang, Ling
Arreaza, Gladys
Maguire, Maureen
Chang, Ken C. N.
Marton, Matthew J.
Levitan, Diane
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
[8] Whole exome sequencing (WES) of non-small cell lung cancer (NSCLC) for tumor mutational burden (TMB) analysis and long-term benefit to immune checkpoint inhibitors (ICIs).
Felip, Enriqueta
Navarro, Alejandro
Callejo, Ana
Martinez Marti, Alex
Cedres, Susana
Pardo, Nuria
Ros, Javier
David Assaf, Juan
Pedrola, Anna
Viaplana, Cristina
Sansano, Irene
Jimenez, Jose
Nuciforo, Paolo
Sanso, Miriam
Dienstmann, Rodrigo
Amat, Ramon
Mancuso, Francesco M.
Vivancos, Ana
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[9] THE CODING GENOME OF CLASSICAL HODGKIN LYMPHOMA (CHL) AS REVEALED BY WHOLE-EXOME SEQUENCING (WES) OF MICRODISSECTED TUMOR CELLS
Tiacci, E.
Penson, A.
Schiavoni, G.
Ladewig, E.
Fortini, E.
Wang, Y.
Rosseto, A.
Venanzi, A.
Gianni, A. M.
Viviani, S.
Cabras, A.
Crescenzi
Mecucci
Pasqualucci
Rabadan
Falini
HAEMATOLOGICA, 2016, 101 : S14 - S14
[10] Association of tumor mutational burden (TMB) and clinical outcomes with pembrolizumab (pembro) versus chemotherapy (chemo) in patients with metastatic triple-negative breast cancer (mTNBC) from KEYNOTE-119.
Winer, Eric P.
Lipatov, Oleg
Im, Seock-Ah
Goncalves, Anthony
Munoz-Couselo, Eva
Lee, Keun Seok
Schmid, Peter
Testa, Laura
Witzel, Isabell
Ohtani, Shoichiro
Lunceford, Jared
Karantza, Vassiliki
Mejia, Jaime Alberto
Cristescu, Razvan
Aurora-Garg, Deepti
Jelinic, Petar
Huang, Lingkang
Cortes, Javier
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →